AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06081088 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy
Description: Conventional physiotherapy program includes passive, active-assistive (wand exercises) and active ROM exercises for shoulder joint, passive / active posterior and anterior capsule stretching exercises, superior-inferior, mediolateral and distraction techniques for scapular mobilization exercises, shoulder flexion, abduction, internal and external rotation muscles strengthening exercises, static and dynamic stabilization exercises for proprioception exercises. To reduce the pain that may occur after exercises, cold application and Transcutaneous Electrical Nerve Stimulation (TENS) will be applied to benefit from their analgesic effects. Cold application will be applied around the shoulder using a coldpack (gel pack) cold therapy for 15 minutes. Conventional TENS application around shoulder will be performed using a TENS device and four separate 2 × 2 inch self-adhesive electrodes for 15 minutes.This program will be applied for 6 weeks (3 sessions per week).
Study NCT06328348 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: supplementation
Description: group receiving a course of Black Cohosh, Soy Isoflavones, and SDG Lignans
Study NCT06328348 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT06081088 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home Exercise Program
Description: The home exercises program includes shoulder jonit active ROM exercises, active posterior and anterior shoulder capsule stretching exercises, shoulder flexion, abduction, internal and external rotation muscles strengthening exercises, shoulder proprioception exercises, and cold therapy. This program will be applied for 6 weeks (3 sessions per week).
Study NCT06081088 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise Program
Description: The home exercises program includes shoulder jonit active ROM exercises, active posterior and anterior shoulder capsule stretching exercises, shoulder flexion, abduction, internal and external rotation muscles strengthening exercises, shoulder proprioception exercises, and cold therapy. This program will be applied for 6 weeks (3 sessions per week).
Study NCT06023667 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMART-IBD
Description: Daily medication and diary completion reminders are provided to participants. Additional educational content regarding self-management skills will be provided.
Study NCT06018701 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: A dental device made of zirconia. This is a new invention and does not exist generically. The given generic name of the invention (dental device) is Dantya Nikhan.
Description: Dental device is surgically placed and cemented with PMMA bone cement on edentulous region.
Study NCT04573673 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PTNS de verum
Description: The device will be set to program P-4: Frequency 20Htz, Pulse duration = 200 µs. The amplitude (Volt) will be adjusted by the patient according to the feeling.
Study NCT04573673 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: PTNS placebo
Description: The device will be set to program P-4: Frequency 20Htz, Pulse duration = 200 µs. A resistor will be incorporated in the device to block the passage of electric current
Study NCT04414072 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sleeve gastrectomy with loop bipartition
Description: operations to decrease weight
Study NCT05086783 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video-based coaching
Description: The coaching session will follow the Wisconsin Coaching Framework (Greenberg 2015). The surgical coaching session will last at maximum 30 minutes and will occur within 1-2 week following the procedure. The surgical coaching session will occur over Zoom. The second attempt will occur within 1 week following the coaching session.
Study NCT05086783 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard surgical teaching (master-apprentice model - (MAM))
Description: Standard surgical teaching that conventionally occurs in the operating room follows a master-apprentice model (MAM).
Study NCT05086783 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard surgical teaching (master-apprentice model - (MAM))
Description: Standard surgical teaching that conventionally occurs in the operating room follows a master-apprentice model (MAM).
Study NCT04720638 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short fiber reinforced flowable resin composite restorations
Description: reinforced flowable resin composite
Study NCT04720638 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional resin composite restoration
Description: Microhybrid resin composite
Study NCT05062434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Academic detailing and audit and feedback intervention
Description: An academic detailing and audit and feedback intervention will be presented to VA cardiac electrophysiologists, and will include quantitative data about the individual physician's facilities cardiovascular implantable electronic device lead implants and national data on lead implants over the past year.
Study NCT05896280 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: EST
Description: Stones are taken by cutting the papillary sphincter
Study NCT05896280 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: EST
Description: Stones are taken by cutting the papillary sphincter
Study NCT05896280 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ECPP
Description: During ERCP, a generous biliary sphincterotomy (>1 cm) will be performed to facilitate large stone extraction by use of a lithotripsy basket and a stone extraction balloon. After all stone fragments were cleared from the bile duct, this group will undergo ECPP after EST. A single-pigtail biliary stent will be placed (suspended overlength biliary stent, 7F × 20 cm). Then the rotatable repeatable opening and closing of soft tissue clamps (referred to as harmony clips, Mico-Tech, ROCC-D-26-195) should be applied to extend the bile duct axially, linear clamp the incised duodenal papilla, taking care to avoid clamping the bile duct stent, and removing the bile duct stent 3 weeks after ECPP.
Study NCT05662514 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis BLa80
Description: Test product contain 3 × 109 colony-forming units \[CFU\] Bifidobacterium animalis subsp. lactis BLa80 strains, for each packet.~Subjects ingested one packet (3 g/packet) of Test product per day (2 hours after taking antibiotics in the evening), for 14 days.
Study NCT05662514 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: To maintain the blinding, patients in the control group received placebo included in identical packets. Control product per day (2 hours after taking antibiotics), for 14 days.
Study NCT06411093 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Kinesiology tape wrapping
Description: Place Kinesiology tape between the nail plate and the inflamed periungual granulation tissue in addition to conventional treatment for 3 months
Study NCT06411093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Conventional treatment including silver nitrate cauterization
Description: Conventional treatment including silver nitrate cauterization, with or without topical antiseptics, topical steroids, topical beta-blockers, short-term systemic antibiotics, systemic steroids for 3 months
Study NCT06411093 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment including silver nitrate cauterization
Description: Conventional treatment including silver nitrate cauterization, with or without topical antiseptics, topical steroids, topical beta-blockers, short-term systemic antibiotics, systemic steroids for 3 months
Study NCT05723432 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KD6001
Description: KD6001 will be administered intravenously.
Study NCT05723432 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Toripalimab will be administered intravenously.
Study NCT05275985 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 68Ga-FAPI Positron Emission Tomography-Computed Tomography
Description: The patients with suspected pancreatic lesions were included. They underwent 68Ga-FAPI PET/CT to distinguish benign and malignant lesions, to evaluate the resectability of lesions and to detect distant metastasis. The treatment methods were decided according to the results of 68Ga-FAPI PET/CT.
Study NCT05800652 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer Mentoring Program
Description: Mentoring program created in academic, social, emotional and safety dimensions.In the academic dimension, there is information about the instructors, course selection, preparing a course study program,efficient study methods,information about the education and training program. Social dimension includes interpersonal relations, participation in social life, free time activities, making friends.The emotional dimension includes developing self-confidence,coping with stress,belonging and motivation.In the security dimension, there are student rights,scholarship opportunities, accommodation opportunities, library and internet facilities, use of the health center and clinical practice. In the mentoring program, it was expected that the mentors would make individual meeting(s) with the mentee they were matched with, face to face, online or over the phone, and share information and support every week. The mentoring program continued for 12 weeks.
Study NCT04772807 — intervention group
Intervention type: DEVICE
Intervention: Kinocardiograph
Description: Measure with the Kinocardiograph device and the Okcardio application installed on a smartphone
Study NCT05229445 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: continuous glucose monitor based insulin bolus calculator
Description: Participants will use the bolus calculator with meals to calculate their insulin bolus doses
Study NCT05304481 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ATL administration
Description: Subjects have ATL administration using intravenous infusion
Study NCT04813705 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Reduced dose
Description: The patients with CMR and more than 70% PMR at 25th fraction will receive reduced-dose radiotherapy for 30 fractions.
Study NCT04813705 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Conventional dose
Description: The patients who do not achieve CMR or 70% PMR at 25th fraction will receive conventional dose radiotherapy for 33 fractions.
Study NCT04813705 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: The patients with stage II will receive concurrent cisplatin during Intensity modulated radiotherapy (IMRT), and stage III-IVA patients will receive platinum based induction chemotherapy every 21 days for at least two cycles followed by concurrent cisplatin during IMRT.
Study NCT04813705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: The patients with stage II will receive concurrent cisplatin during Intensity modulated radiotherapy (IMRT), and stage III-IVA patients will receive platinum based induction chemotherapy every 21 days for at least two cycles followed by concurrent cisplatin during IMRT.
Study NCT05450614 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thrive app
Description: The application has already been developed using the Flutter framework and provides users with the main CBT-based strategies to reduce depressive symptoms. In order to engage users, gamification strategies were also implemented. Some examples are 1) development and achievement: quiz on psychoeducation with rewards; 2) epic sense: like the messages in the psychoeducation session; 3) unpredictability: surprise quiz. An avatar will also be available for the participant, who will gain experience as he interacts with some of the application's functions. Finally, participants will receive weekly videos of less than 5 minutes with tips on how to use the app. There will be a total of 12 videos with psychoeducation tips and how to use the application.
Study NCT05450614 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TCCG
Description: In the literature, there is no single protocol for the treatment of depression through CBCT, therefore, a systematized protocol was developed for this study, aiming to structure and unify this intervention. Participants selected for the TCCG group will be randomly divided into 10 groups of 10 members each. The TCCG will be held through weekly meetings, exclusively online. Twelve sessions lasting 90 minutes each will be applied. The structuring of the sessions is based on the cognitive-behavioral model, starting with psychoeducation about the disorder and self-knowledge, starting with cognitive restructuring and relapse prevention. Homework will be part of the protocol. The sessions will be held on a digital platform (Google Meet) and access instructions will be provided to the participants of this group in the evaluation interview.
Study NCT04764214 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3rd generation EGFR-TKI
Description: Osimertinib will be administered orally at the dose of 80 mg once daily.
Study NCT05277948 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: active thumbtack needle
Description: The following 12 acupoints including conception vessel (CV) 4, CV3, bilateral ovary acupoints, bilateral spleen (SP) 6, bilateral stomach (ST) 36, bilateral bladder (BL) 23 and bilateral EX-B7 will be used. Eight points of CV4, CV3, SP6, ST36 and BL23 were treated by the sterile thumbtack needle for single use (Hangzhou Zhuomai Medical Technology Co., LTD., model: ZM2-6YDL), and four points of bilateral ovary acupoints and bilateral EX-B7 were treated by disposable sterile electro-thumbtack needle (Hangzhou Zhuomai Medical Technology Co., LTD., model: ZM3-ZY).~The patients were receive a treatment of 2 menstrual cycles
Study NCT05277948 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: sham thumbtack needle
Description: The following 12 acupoints including conception vessel (CV) 4, CV3, bilateral ovary acupoints, bilateral spleen (SP) 6, bilateral stomach (ST) 36, bilateral bladder (BL) 23 and bilateral EX-B7 will be used. Eight points of CV4, CV3, SP6, ST36 and BL23 were treated by the sterile sham thumbtack needle for single use (Hangzhou Zhuomai Medical Technology Co., LTD., model: ZM2-6YDL), and four points of bilateral ovary acupoints and bilateral EX-B7 were treated by disposable sterile sham electro-thumbtack needle (Hangzhou Zhuomai Medical Technology Co., LTD., model: ZM3-ZY).~The patients were receive a treatment of 2 menstrual cycles
Study NCT04764214 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Consolidative SRT
Description: Patients who possess oligoresidual disease after 3rd generation EGFR-TKI therapy will be treated with the intent to ablate all residual disease with consolidative SRT. The choice of dose-fractionation regimen is at the discretion of the treating radiation oncologist. TKI will be continued during and after consolidative SRT until disease progression or intolerable toxicity.
Study NCT05571683 — intervention group
Intervention type: OTHER
Intervention: oxygen support
Description: 40 patients (2 arms) will be supported with 2 l/min oxygen and the other 2 arms (40 patients) will be supported with 4 l/min oxygen under the surgical drapes.
Study NCT06419530 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Probiotic formula capsule
Description: The subjects take 4 capsules a day for 84 days.
Study NCT06419530 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo capsule
Description: The subjects take 4 capsules a day for 84 days.
Study NCT06419530 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: FMT capsule
Description: The subjects take 4 capsules a day for 84 days.
Study NCT06411171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy (FLOT)
Description: The experimental group was treated with pembrolizumab combined with FLOT, and the control group was treated with FLOT chemotherapy alone
Study NCT06411171 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab plus chemotherapy (FLOT)
Description: The experimental group was treated with pembrolizumab combined with FLOT, and the control group was treated with FLOT chemotherapy alone
Study NCT05324904 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D
Description: - Vitamin D~* The aqueous solution of vitamin D3 (cholecalciferol) will be used ampoule 200,000 IU/2 ML,~* Using a 27-gauge syringe with the bevel facing upward, a maximum of 0.6 ml (60,000 IU) of vitamin D3 solution will be slowly injected into the base of the largest plantar wart (large warts > 10 mm need multiple injections at different sites)~* Treatment sessions will be performed at 3-week intervals for a maximum of 4 sessions
Study NCT05324904 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: acyclovir
Description: -Acyclovir~* Acyclovir vial (Zovirax® vial, 250mg, ) will be diluted with 3.5 ml saline to get approximately 70 mg /ml solution.~* After sterilization of the skin, a 27-gauge syringe with the bevel facing upward will be inserted into the base of the largest plantar wart to slowly inject the solution~* Treatment sessions will be performed at 2-week intervals for maximum of 5 sessions
Study NCT06277453 — intervention group
Intervention type: OTHER
Intervention: surgery
Description: radical gastric cancer surgery (R0) and D2 lymph node dissection
Study NCT06501846 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pipelle® endometrial biopsy performed under transabdominal ultrasound guidance
Description: The placement of an ultrasound probe on the lower abdomen while a Pipelle® endometrial biopsy is obtained.
Study NCT06501846 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Pipelle® endometrial biopsy performed without ultrasound guidance
Description: A Pipelle® endometrial biopsy is performed by using touch alone.
Study NCT05306132 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASKC202
Description: Dosage Forms: Tablets; Administration: Oral administration
Study NCT05095142 — intervention group
Intervention type: GENETIC
Intervention: SNP analysis of the DNA
Description: SNP analysis of the DNA obtained from peripheral blood sample
Study NCT05883098 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wound debridement
Description: The study's wounds will be mechanically debrided before the experimental or active comparator devices are applied. Debridation will be performed by a trained clinician using a curette. Necrotic tissue and slough will be removed during this procedure.
Study NCT05883098 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wound debridement
Description: The study's wounds will be mechanically debrided before the experimental or active comparator devices are applied. Debridation will be performed by a trained clinician using a curette. Necrotic tissue and slough will be removed during this procedure.
Study NCT05883098 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wound closure matrix application
Description: After wound debridement, the patients will receive the application of a wound closure matrix as dictated by their randomization allocation.
Study NCT05883098 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wound closure matrix application
Description: After wound debridement, the patients will receive the application of a wound closure matrix as dictated by their randomization allocation.
Study NCT05050591 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Patient-Specific Silicone Airway Stent
Description: The Patient-Specific Airway Stent is a silicone stent indicated for use in adults that have stenosis of the airway. Current silicone stents have stock dimensions that do not conform to the patient's airway anatomy. The subject device takes a CT scan, thresholds out the airway from the other anatomy, and allows the physician to digitally design the stent to his/her desired dimensions. Finally, according to the physician's design, a patient-specific stent can be manufactured using additive manufacturing technology. The patient-specific stent is indicated for use with any rigid bronchoscopy/stent application system that fits the design envelope.
Study NCT05714319 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Variables collected will include:~* demographics (sex, age)~* comorbidities (type 2 diabetes mellitus, familiar history of CAD, smoke habit, dyslipidaemia, hypertension, history of CAD)~* echocardiographic (left ventricle ejection fraction at admission, the presence and grade of diastolic dysfunction, and the presence and grade of any valvulopathies)~* angiographic data (presence of non-obstructive CAD (any coronary lesion \<50% diameter stenosis), the presence of myocardial bridge and, if this latter is present, its localization and length)~* laboratory measurements (hematologic variables (haemoglobin and white blood cells), creatinine, high sensitivity cardiac troponin I (hs-cTnI), and C-reactive protein (CRP) at the time of admission)~* medical therapy at admission~* response to intracoronary provocative test with ACh.
Study NCT05714319 — intervention group
Intervention type: OTHER
Intervention: Clinical follow-up
Description: All patients will undergo a clinical follow-up by telephonic interview and/or clinical visit at 6, 12, 24, 36, 48 and 60 months from hospital discharge, during which the incidence of MACCE in the past months will be investigated and collected.